The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases
Official Title: A Randomized, Open-label, Controlled, Multi-center Phase II Study to Evaluate the Efficacy and Safety of Adecatumumab Alone or Sequentially to FOLFOX Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases
Study ID: NCT00866944
Brief Summary: The purpose of this study is to determine the effect of adecatumumab alone or following FOLFOX in patients with R0 resected liver metastases from CRC (colorectal carcinoma) and to compare the effect to FOLFOX alone.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Centre Paul Strauss, Strasbourg, , France
Zentralklinikum Augsburg, Augsburg, , Germany
Klinikum am Bruderwald, Sozialstiftung Bamberg, Bamberg, , Germany
CharitĂŠ Campus Virchow Klinikum, Berlin, , Germany
Klinikum der Heinrich-Heine Universität, Dßsseldorf, , Germany
J.W. Goethe-Universität, Frankfurt, , Germany
Martin-Luther Universität, Halle, , Germany
Medizinische Hochschule Hannover, Hannover, , Germany
Universitätsklinikum Leipzig, Leipzig, , Germany
Klinikum Magdeburg gGmbH, Magdeburg, , Germany
Klinikum der Johannes-Gutenberg Universität, Mainz, , Germany
Klinikum Mannheim GmbH Universitätsklinikum, Mannheim, , Germany
Universitätsklinikum der LMU Grosshadern, Mßnchen, , Germany
Städtisches Klinikum Neuperlach, Mßnchen, , Germany
Klinikum Oldenburg gGmbH, Oldenburg, , Germany
Klinikum der Universität Regensburg, Regensburg, , Germany
Name: Peter Neuhaus, Prof. Dr.
Affiliation: CharitĂŠ Campus Virchow Klinikum, Berlin
Role: PRINCIPAL_INVESTIGATOR
Name: Patrick Dufour, Pr. Dr.
Affiliation: Centre Paul Strauss, Strasbourg
Role: PRINCIPAL_INVESTIGATOR